Our CEO Martin Munte participated in the MeetAustria26 event on invitation of Austrian Business Agency, which offered a valuable opportunity to engage with industry leaders and fellow CEOs within the healthcare sector. The discussions focused on utilizing the Austrian Industrial Strategy 2035 to advance the interests of biotech firms such as Vaccentis, with the objective of fostering technological innovation to enhance care for oncology patients.
